Coxsackievirus B3 Antibody Test
This blood test detects antibodies your body makes against Coxsackievirus B3, a virus that can affect the heart and other organs.
{"This test checks for antibodies to Coxsackievirus B3 in your blood","It helps diagnose heart infections like myocarditis caused by this virus","The test requires a simple blood draw","Positive results may indicate recent or past infection","Results are reported as positive, negative, or equivocal"}
Key facts at a glance
- LOINC
- 30222-4
- Short code
- COXB3 Ab
- Synonyms
- CV B3 Ab Ser Ql
- Category
- cardiac
- Sample
- serum
- Container
- Serum separator tube (SST, gold top) or plain red top tube
- Units
- N/A
- Ref low
- 0
- Ref high
- 1
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Enzyme-linked immunosorbent assay (ELISA) or immunofluorescence assay (IFA)
- CPT
- 86658
- SNOMED
- 122442009
- Specimen volume
- 1.0-2.0 mL serum minimum
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 20
- TAT
- 48–96 hours
- Order
- routine
What is this test?
The Coxsackievirus B3 antibody test is a blood test that checks for specific antibodies (IgM and IgG) that your immune system produces in response to a Coxsackievirus B3 infection. This virus belongs to the enterovirus family and is known to cause infections that can involve the heart, muscles, and nervous system.
Why is it ordered?
Doctors typically order this test when you have symptoms of a heart infection, such as chest pain, shortness of breath, a rapid heartbeat, or fatigue, especially after a recent viral illness. It helps determine whether Coxsackievirus B3 is causing your heart-related symptoms. In the cardiac category, it is commonly used to help evaluate myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining around the heart).
How is the test performed?
A healthcare professional will draw a small blood sample from a vein in your arm. The sample is then sent to a laboratory and tested for IgM and IgG antibodies against Coxsackievirus B3. IgM antibodies usually appear early in the infection and suggest a recent infection, while IgG antibodies develop later and may point to a past infection or immunity.
What do the results mean?
Results are typically reported as Positive, Negative, or Equivocal. A positive result means antibodies were found, suggesting you currently have or recently had a Coxsackievirus B3 infection. A negative result means no antibodies were detected, indicating no current or past infection, or that the infection is too recent to detect. An equivocal result means the test could not clearly confirm whether antibodies are present, and your doctor may recommend retesting.
Reference range
Negative: < 1:8 titer; Equivocal: 1:8 titer; Positive: >= 1:16 titerN/A
No special preparation required. Patient may eat and drink normally before sample collection.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Do I need to fast before this test?
How long does it take to get results?
Is the test dangerous?
What happens if my test is positive?
Can I get this infection again?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 14, 2026. · Read our editorial policy